Skip to main content

What is the difference between Rituxan and Rituxan Hycela?

Medically reviewed by Kristianne Hannemann, PharmD. Last updated on March 27, 2025.

Official Answer by Drugs.com

Key Points

Rituxan vs. Rituxan Hycela: Key Differences

Rituxan Hycela (rituximab and hyaluronidase human) includes the same monoclonal antibody as Rituxan (rituximab), but in combination with hyaluronidase, an enzyme that helps to deliver rituximab by subcutaneous injection under the skin. The original Rituxan is given only by intravenous (IV) infusion.

Administration Method

Rituxan Hycela is administered via subcutaneous injection to adults with the following blood cancers:

Rituxan is administered via intravenous infusion for the following conditions:

Related questions

Composition

Treatment time

Who Can Receive Rituxan Hycela?

Rituxan Hycela is only for patients who have previously received at least one full IV dose of Rituxan to ensure they tolerate the medication.

Which One Is Right for You?

Clinical studies showed Rituxan Hycela delivered similar blood levels and effectiveness of rituximab; however, the majority (77 percent) of patients preferred Rituxan Hycela over IV Rituxan due to less time spent in the clinic.

Your doctor will determine whether Rituxan or Rituxan Hycela is best based on your medical history, condition, and treatment goals. Rituxan Hycela offers a shorter administration time, but not all patients are eligible for the switch from IV to SC.

Both medications have similar side effects and require monitoring for adverse reactions. Always consult your doctor for personalized medical advice before starting or switching treatments.

This is not all the information you need about Rituxan or Rituxan Hycela. Review the full prescribing information and discuss it with your healthcare provider.

References
  1. Rituxan Hycela [package insert]. 2024. Genentech, Inc. Accessed March 27, 2025 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e5b7e82-f018-4eaf-ae78-d6145a906b20
  2. Rituxan [package insert]. 2025. Genentech, Inc. Accessed March 27, 2025 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b172773b-3905-4a1c-ad95-bab4b6126563

Read next

What is the success rate of Rituxan (rituximab) in patients with blood cancers?

In patients with hematological or blood cancers, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL), Rituxan’s success is measured in a number of ways. It is measured by looking at how long patients responded to treatment (median duration of response), how long they live without their disease progressing (progression-free survival) and how many patients respond to treatment (response rate).

Rituxan treatment improves outcomes in certain patients with NHL. Adding Rituxan alongside standard therapies enhances the response patients have to treatment and improves overall outcomes, including increasing the time patients live for without experiencing a progression of their disease.

Rituxan helps to improve overall survival in certain patients with CLL and also helps to increase the time patients live for without experiencing disease progression. Adding Rituxan alongside standard therapy enhances the response patients have to therapy. Continue reading

What is a chemotherapy regimen?

A chemotherapy (chemo) regimen consists of anti-cancer medicines you receive over a set period of time (usually over several cycles). Chemo regimens, such as R-CHOP, are often abbreviated by using the first letter of the drug names. For example, R-CHOP is an abbreviation for a 5-drug chemotherapy regimen used to treat non-Hodgkin’s lymphoma, a type of blood cancer.

Continue reading

What is the success rate of Rituxan (rituximab) in rheumatoid arthritis?

Treatment with Rituxan (rituximab) successfully improves patient outcomes in patients with rheumatoid arthritis including reducing symptoms, reducing levels of fatigue and disability, and increasing health-related quality of life. It also slows the progression of structural damage in joints. Continue reading

See also:

Related medical questions

Drug information

Related support groups